{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:09:26Z","timestamp":1759342166743},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T00:00:00Z","timestamp":1204502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s11239-008-0208-z","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T12:37:55Z","timestamp":1204547875000},"page":"329-333","source":"Crossref","is-referenced-by-count":17,"title":["The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura"],"prefix":"10.1007","volume":"27","author":[{"given":"Semir","family":"Pasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timucin","family":"Cil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan","family":"Danis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Ayyildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,3]]},"reference":[{"key":"208_CR1","first-page":"18","volume":"71","author":"R Yang","year":"2000","unstructured":"Yang R, Han ZC (2000) Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update. Int J Hematol 71:18\u201324","journal-title":"Int J Hematol"},{"key":"208_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008415","volume":"6","author":"PO Andersson","year":"2004","unstructured":"Andersson PO, Wadenvik H (2004) Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy. Expert Rev Mol Med 6:1\u201317","journal-title":"Expert Rev Mol Med"},{"key":"208_CR3","doi-asserted-by":"crossref","unstructured":"Zhou Z, Yang R. (2007) Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura. Crit Rev Oncol Hematol, doi: 10.1016\/j.critrevonc.2007.06.007","DOI":"10.1016\/j.critrevonc.2007.06.007"},{"key":"208_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajh.20276","volume":"78","author":"P Braendstrup","year":"2005","unstructured":"Braendstrup P, Bjerrum OW, Nielsen OJ et\u00a0al (2005) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 78:275\u2013280","journal-title":"Am J Hematol"},{"key":"208_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1600-0609.2002.02686.x","volume":"69","author":"AA Giagounidis","year":"2002","unstructured":"Giagounidis AA, Anhuf J, Schneider P et\u00a0al (2002) Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. Eur J Haematol 69:95\u2013100","journal-title":"Eur J Haematol"},{"key":"208_CR6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2141.2004.04889.x","volume":"125","author":"N Cooper","year":"2004","unstructured":"Cooper N, Stasi R, Cunningham-Rundles S et\u00a0al (2004) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 125:232\u2013239","journal-title":"Br J Haematol"},{"key":"208_CR7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00277-006-0123-3","volume":"85","author":"FJ Pe\u00f1alver","year":"2006","unstructured":"Pe\u00f1alver FJ, Jim\u00e9nez-Yuste V, Almagro M et\u00a0al (2006) Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Ann Hematol 85:400\u2013406","journal-title":"Ann Hematol"},{"key":"208_CR8","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","volume":"107","author":"CM Bennett","year":"2006","unstructured":"Bennett CM, Rogers ZR, Kinnamon DD et\u00a0al (2006) Prospective phase 1\/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 107:2639\u20132642","journal-title":"Blood"},{"key":"208_CR9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","volume":"98","author":"R Stasi","year":"2001","unstructured":"Stasi R, Pagano A, Stipa E et\u00a0al (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for chronic idiopathic thrombocytopenic purpura. Blood 98:952\u2013957","journal-title":"Blood"},{"key":"208_CR10","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2002-02-0392","volume":"99","author":"R Stasi","year":"2002","unstructured":"Stasi R, Stipa E, Forte V et\u00a0al (2002) Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood 99:3872\u20133873","journal-title":"Blood"},{"key":"208_CR11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1440-1754.2005.00641.x","volume":"41","author":"M Moschovi","year":"2005","unstructured":"Moschovi M, Trimis G, Pergantou H et\u00a0al (2005) Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura. J Paediatr Child Health 41:384\u2013386","journal-title":"J Paediatr Child Health"},{"key":"208_CR12","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","volume":"104","author":"K Kojouri","year":"2004","unstructured":"Kojouri K, Vesely SK, Terrell DR et\u00a0al (2004) Splenectomy for adults patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count response, prediction of response, and surgical complications. Blood 104:2623\u20132634","journal-title":"Blood"},{"key":"208_CR13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00277-002-0461-8","volume":"81","author":"S Kumar","year":"2002","unstructured":"Kumar S, Diehn FE, Gertz MA et\u00a0al (2002) Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81:312\u2013319","journal-title":"Ann Hematol"},{"key":"208_CR14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4065\/79.4.504","volume":"79","author":"R Stasi","year":"2004","unstructured":"Stasi R, Provan D (2004) Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 79:504\u2013522","journal-title":"Mayo Clin Proc"},{"key":"208_CR15","first-page":"4","volume":"90","author":"N Vianelli","year":"2005","unstructured":"Vianelli N, Galli M, de Vivo A et\u00a0al (2005) Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 90:4","journal-title":"Haematologica"},{"key":"208_CR16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10253","volume":"72","author":"J Schwartz","year":"2003","unstructured":"Schwartz J, Leber MD, Gillis S et\u00a0al (2003) Long-term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 72:94\u201398","journal-title":"Am J Hematol"},{"key":"208_CR17","first-page":"99","volume":"27","author":"MN Saleh","year":"2000","unstructured":"Saleh MN, Gutheil J, Moore M et\u00a0al (2000) A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Semin Oncol 27:99\u2013103","journal-title":"Semin Oncol"},{"key":"208_CR18","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","volume":"97","author":"JE Portielje","year":"2001","unstructured":"Portielje JE, Westendorp RG, Kluin-Nelemans HC et\u00a0al (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549\u20132554","journal-title":"Blood"},{"key":"208_CR19","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","volume":"107","author":"CM Bennett","year":"2006","unstructured":"Bennett CM, Rogers ZR, Kinnamon DD et\u00a0al (2006) Prospective phase 1\/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 107:2639\u20132642","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-008-0208-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-008-0208-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-008-0208-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:01:38Z","timestamp":1559386898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-008-0208-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1007\/s11239-008-0208-z","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,3]]}}}